Cardiometabolic Disease
7
2
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (7)
Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
Building Access to Food Through Systems and Solidarity (BASIS): A Subsidized and Culturally-adapted Produce Box Program for Immigrant Communities of Brooklyn, NY
HomeStyles-Adults of Chinese Heritage
The Impact of Faba Bean Rich Bread on Iron Status, Postprandial Lipaemia and Satiety
Telehealth Integrated Care Model in Patients With Cardiometabolic Disease
A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk
Metagenomics and Integrative Systems Medicine of Cardiometabolic Diseases